A mathematical model of cancer treatment by immunotherapy.

[1]  P. Unger,et al.  Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  O. Scott.  Biologic therapy of cancer. , 1996, British Journal of Cancer.

[3]  H. I. Freedman,et al.  Can Mutualism Alter Competitive Outcome?: A Mathematical Analysis , 1995 .

[4]  H. I. Freedman,et al.  Persistence in predator-prey systems with ratio-dependent predator influence , 1993 .

[5]  M. Caligiuri,et al.  Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. , 1993, The Journal of clinical investigation.

[6]  H. I. Freedman,et al.  Hopf bifurcation in three-species food chain models with group defense. , 1992, Mathematical biosciences.

[7]  The biology & clinical applications of interleukin-2 , 1992 .

[8]  V. Devita,et al.  Biologic Therapy of Cancer , 1992 .

[9]  J. McCluskey.  Antigen Processing and Recognition , 1991 .

[10]  P W Mansell,et al.  Pharmacokinetics of recombinant interleukin 2 in humans. , 1990, Cancer research.

[11]  S. Wiggins.  Introduction to Applied Nonlinear Dynamical Systems and Chaos , 1989 .

[12]  Adoptive cellular immunotherapy of cancer. , 1989, Immunology series.

[13]  Immunology essentials of surgical practice , 1988 .

[14]  T. Kalland,et al.  Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells. , 1987, Journal of immunology.

[15]  Paul Waltman,et al.  Uniformly persistent systems , 1986 .

[16]  A. Chang,et al.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. , 1985, The New England journal of medicine.

[17]  S. Rosenberg.  Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. , 1985, Journal of the National Cancer Institute.

[18]  H. I. Freedman,et al.  Persistence in a model of three competitive populations , 1985 .

[19]  G. Stampacchia,et al.  Ordinary Differential Equations in Rn: Problems and Methods , 1984 .

[20]  S J Merrill,et al.  A model of the role of natural killer cells in immune surveillance — I , 1981, Journal of mathematical biology.

[21]  Howard Whitley Eves,et al.  Elementary Matrix Theory , 1980 .

[22]  Z. Zawadzki,et al.  Circulating immune complexes in patients with neoplastic disorders. , 1980, Oncology.

[23]  Solomon Lefschetz,et al.  Stability by Liapunov's Direct Method With Applications , 1962 .